Filing Flows › GoodRx Holdings (GDRX) › Q4 2024
GoodRx Holdings (GDRX) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Feb 27, 2025
GoodRx Holdings (GDRX) reported revenue of $199M for the fourth quarter 2024 (Q4 2024), +1% from a year earlier and +2% from the quarter before. Operating margin was 9.2%, net earnings $6.7M (3.4% of revenue).
GoodRx Holdings, Q4 2024: revenue $199M (+1% year over year), operating margin 9.2%, net earnings $6.7M, operating cash flow $44.7M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $199M | +2% | +1% |
| Operating profit | $18.2M | -11% | — |
| Net earnings | $6.7M | +70% | — |
| Operating cash flow | $44.7M | -48% | +182% |
| Free cash flow | $44.6M | -48% | +188% |
What changed
Revenue was $198.6M in Q4 2024, up 1% year over year and up 2% from the previous quarter. Prescription transactions revenue was the largest line at 73% of revenue.
Operating profit was $18.2M, a 9.2% margin (up 18.5 points year over year). Total costs fell 16% while revenue rose 1%. Net earnings were $6.7M. The effective tax rate was 40.9%.
Operating cash flow was $44.7M (up 182% year over year), 664% of net earnings. Non-cash charges added back $19.1M of depreciation and amortization and $21.0M of share-based compensation. Capital expenditures of $162K left free cash flow of $44.6M.
Questions
What was GoodRx Holdings' revenue in the fourth quarter 2024?
GoodRx Holdings (GDRX) reported revenue of $199M for the fourth quarter 2024 (Q4 2024), +1% from a year earlier and +2% from the quarter before.
Was GoodRx Holdings profitable in the fourth quarter 2024?
Operating profit was $18.2M (9.2% of revenue) and net earnings $6.7M.
Source: GoodRx Holdings 10-K on SEC EDGAR.